Graves – Immunovant IMVT-1402-2505

Participating in a clinical trial with Profound means making a real difference in the lives of others facing similar health challenges.

This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 of 3 study groups (Groups A, B and C) based on their GD status at the completion of their respective feeder study.

Inclusion Criteria:

  • Participants who completed Study IMVT-1402-2502 or Study IMVT-1402-2503.
  • Other, more specific inclusion criteria are defined in the protocol.
  • Other criteria may apply

Complete the form and our team will reach out soon to help determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

Locations

Michigan Healthcare Professionals TriAtria

32255 Northwestern Hwy
Suites 130 & 160
Farmington Hills, Michigan